Evidence map›Paper›PMID 24668606›Full record

ArticleMolecular nutrition & food research2015

Aflatoxin exposure is inversely associated with IGF1 and IGFBP3 levels in vitro and in Kenyan schoolchildren.

Jovita M Castelino, Michael N Routledge, Shona Wilson, David W Dunne, Joseph K Mwatha, Kimani Gachuhi, Christopher P Wild, Yun Y Gong

Open access · greenAbstract read
In one paragraph

Article in Molecular nutrition & food research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Aflatoxin exposure and health impacts: global burden and advances in detection technologies.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Research Progress and Treatment Status of Liver Cirrhosis with Hypoproteinemia.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Risk assessment of aflatoxins in food.EFSA journal. European Food Safety Authority · 2020
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Jovita M CastelinoDivision of Epidemiology, School of Medicine, University of Leeds, Leeds, UK.
Michael N Routledge
Shona Wilson
David W Dunne
Joseph K Mwatha
Kimani Gachuhi
Christopher P Wild
Yun Y Gong
University of Leeds · GBKenya Medical Research Institute · KEUniversity of Cambridge · GBCentre International de Recherche sur le Cancer · FR

Funding

Validation and Application of Risk, Biomarkers in Human StudiesP01ES006052 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI GROOPMAN, JOHN D · 1993 to 2012
$22.6M
NIEHS NIH HHS ES06052NIEHS NIH HHS P01 ES006052World Health Organization 001
6 · The paper itself

Abstract

scopeThis study explores the relationship between aflatoxin and the insulin-like growth factor (IGF) axis and its potential effect on child growth. METHODS AND

resultsOne hundred and ninety-nine Kenyan schoolchildren were studied for aflatoxin-albumin adduct (AF-alb), IGF1 and IGF-binding protein-3 (IGFBP3) levels using ELISA. AF-alb was inversely associated with IGF1 and IGFBP3 (p < 0.05). Both IGF1 and IGFBP3 were significantly associated with child height and weight (p < 0.01). Children in the highest tertile of AF-alb exposure (>198.5 pg/mg) were shorter than children in the lowest tertile (<74.5 pg/mg), after adjusting for confounders (p = 0.043). Path analysis suggested that IGF1 levels explained ∼16% of the impact of aflatoxin exposure on child height (p = 0.052). To further investigate this putative mechanistic pathway, HHL-16 liver cells (where HHL-16 is human hepatocyte line 16 cells) were treated with aflatoxin B1 (0.5, 5 and 20 μg/mL for 24-48 h). IGF1 and IGFBP3 gene expression measured by quantitative PCR and protein in culture media showed a significant down-regulation of IGF genes and reduced IGF protein levels.

conclusionAflatoxin treatment resulted in a significant decrease in IGF gene and protein expression in vitro. IGF protein levels were also lower in children with the highest levels of AFB-alb adducts. The data suggest that aflatoxin-induced changes in IGF protein levels could contribute to growth impairment where aflatoxin exposure is high.

Indexed as

AdolescentAflatoxin B1AflatoxinsAlbuminsBody HeightBody WeightCell LineChildCross-Sectional StudiesFemaleFood ContaminationHepatocytesHumansInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IKenyaaflatoxin-albumin adductAflatoxin B1AflatoxinsAlbuminsIGF1 protein, humanIGFBP3 protein, humanInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IAflatoxinsChild growthExposure biomarkerIGFBP3Insulin-like growth factor

Identifiers

PMID24668606
PMCPMC4111788
OpenAlexW1981897238

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.